Mettler-Toledo International Inc

Mettler-Toledo International CFO Shawn Vadala sold 2,240 shares at $1,432 per share, totaling about $3.2 million, on August 3, 2026, according to an SEC filing. The transaction was a same-day exercise-and-sell of 2,240 stock options with an exercise price of $595.31. Following the sale, Vadala retains direct ownership of 5,579 shares, valued at approximately $8.1 million based on the August 3 closing price of $1,445. The sale occurred shortly after Mettler-Toledo reported a strong second quarter, with revenue up about 4% to just over $1 billion and adjusted earnings rising 14% to $11.46 per share, driven in part by robust China sales and a one-time $52.4 million tariff refund that boosted gross margin.

The ten research tools and consumables stocks tracked reported mixed first-quarter results, with aggregate revenues beating analysts' consensus estimates by 1.3% and next-quarter revenue guidance coming in 2% above expectations. Mettler-Toledo posted revenues of 947.1 million dollars, up 7.2% year on year and slightly ahead of estimates, though the quarter was mixed overall. Waters Corporation stood out with revenues of 1.27 billion dollars, a 91.5% year-on-year surge that exceeded estimates by 4.5%, and it delivered the biggest analyst estimate beat, highest guidance raise, and fastest revenue growth among its peers. Revvity's revenues of 686.9 million dollars, up 9.3% year on year, missed estimates by 2.6% and it issued full-year guidance below expectations, marking the weakest performance against estimates in the group. Sotera Health Company reported revenues of 280 million dollars, up 10% year on year and beating estimates by 3.6%, while Bruker's revenues of 823.4 million dollars, up 2.7% year on year, topped estimates by 3.4%. Share prices of the group have risen 20.8% on average since the latest earnings results.